Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea

Completed · Phase 2

Conditions studied: Diabetes Mellitus

In brief

The purpose of the study is to assess the safety and efficacy of FK614 in type 2 diabetic subjects receiving sulfonylurea (SU) monotherapy.

Key facts

Study ID
NCT00036192
Run by
Astellas Pharma Inc
People needed
200
Starts
2002-02-01
Expected to finish
2006-03-01
Last updated by the study team
2011-12-09

Who can join

Age: 25 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.